AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study
AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study
Active, not recruiting · NCT01107340 · Registry updated 2024-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hip Dislocation, Congenital, Musculoskeletal Abnormalities, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, arthritic joint disease, arthropathy, avascular necrosis, bone disorder, developmental dysplasia of the hip, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder | Active, not recruiting | Not applicable | 2024-12-16 | NCT01107340 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medacta International SA | 31 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Elective Orthopaedic Centre (EOC) | Epsom | United Kingdom | 3 |
| Uniklinik Balgrist | Zurich | Switzerland | 1 |